KY19382
Experimental compound that activates hair-growth signals, tested only in animals
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research 8
- KY19382 Accelerates Cutaneous Wound Healing via Activation of the Wnt/β-Catenin Signaling Pathway
- KY19382, a novel activator of Wnt/β‐catenin signalling, promotes hair regrowth and hair follicle neogenesis
- KY19382, a novel activator of Wnt/β-catenin signaling, promotes hair re-growth and hair follicle neogenesis
- Wnt/β-catenin signaling activator restores hair regeneration suppressed by diabetes mellitus
- Pyruvate Kinase M2 Accelerates Cutaneous Wound Healing via Glycolysis and Wnt/β-Catenin Signaling
- Pyruvate Kinase M2 Promotes Hair Regeneration by Connecting Metabolic and Wnt/β-Catenin Signaling
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD2
Community 10
- Verteporfin and KY19382 experiment
- Has anyone had experience with mixing ky19382 with Peg400 or other mixtures?
- Does anyone have experience with KY19382?
- Selling KY19382 powder a novel activator of Wnt/β-catenin signaling
- Anyone here ever used KY-19382 or another indirubin analogue?
- Is there hope for creating new hair follicles?
- Any experiences with Ptd-dbm??
- Why was this compound abandoned ?
- Best, possible, or experimental growth agonists that AREN'T MINOXIDIL.
- Summary of future treatments from 2020